TNC and neoplasm: In addition, in vivo studies demonstrated that the U-87MG tumor-bearing mice received DOX encapsulated in nanoliposomes with sulfatide showed an improvement in survival compared with those received DOX encapsulated in nanoliposomes without sulfatide [8], suggesting that sulfatide in the nanoliposome involves in the binding to tenascin-C.